Characteristics of heterogeneity in the expression of vasoconstriction in response to N(G)-monomethyl-L-arginine in isolated canine arteries

European Journal of Pharmacology

Volumn 379, Issue 2-3, 1999, Pages 167-173

  Kikkawa, Kohei ^a   Hoshino, Tomoko ^a   Yamauchi Kohno, Rikako ^a   Murata, Sakae ^a  

^a Discovery Research Laboratory   (Japan)

Author keywords

cGMP; Ion channels; N(G) Monomethyl L arginine (L NMMA); Nitric oxide (NO) synthase inhibitor; Vasoconstriction, heterogenous

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; ARGININE; CALCIUM CHANNEL; CHARYBDOTOXIN; CYCLIC GMP; DEXTRO ARGININE; DILTIAZEM; ION CHANNEL; N(G) METHYLARGININE; NICARDIPINE; NITRIC OXIDE SYNTHASE INHIBITOR; NITROPRUSSIDE SODIUM;

ANIMAL TISSUE; ARTICLE; BLOOD VESSEL TONE; BRAIN ARTERY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOG; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; VASOCONSTRICTION;

ANIMALS; ARTERIES; CHARYBDOTOXIN; CYCLIC GMP; DILTIAZEM; DOGS; ENZYME INHIBITORS; NICARDIPINE; NITRIC OXIDE; OMEGA-N-METHYLARGININE; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 0032704742     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00510-5     Document Type: Article

References (47)

1. Archer S.L., Huang J.M.C., Kampal V., Nelson D.P., Shultz P.J., Weir E.K. Nitric oxide and cGMP causes vasorelaxation by activation of charybdotoxin-sensitive K channel by cGMP-dependent protein kinase. Proc. Natl. Acad. Sci. USA. 91:1994;7583-7587.
2. + channels in dog basilar artery. J. Cereb. Blood Flow Metab. 13:1993;969-977.
3. + channel on pig coronary artery endothelial cells. J. Physiol. 504:1997;537-543.
4. Bolotina V.M., Najibi S., Palacino J.J., Pagano P.J., Cohen R. Nitric oxide directly activated calcium-dependent potassium channels in vascular smooth muscle. Nature. 28:1994;850-853.
5. Brayden J.E., Nelson M.T. Regulation of arterial tone by activation of calcium-dependent potassium channels. Science. 256:1992;532-535.
6. Brain J.E. Jr., Kennedy R.H. Modulation of cerebral arterial tone by endothelium-derived relaxing factor. Am. J. Physiol. 264:1993;H1245-H1250.
7. Brian J.E. Jr., Faraci F.M., Heistad D.D. Recent insight into the regulation of cerebral circulation. Clin. Exp. Pharmacol. Physiol. 23:1996;449-457.
8. Busse R., Mülsch A., Fleming I., Hecker M. Mechanisms of nitric oxide release from the vascular endothelium. Circulation. 87:1993;V18-V25. Suppl.
9. Cohen R.A., Vanhoutte P.M. Endothelium-dependent hyperpolarization: beyond nitric oxide and cyclic GMP. Circulation. 92:1995;3337-3349.
10. Cosentino F., Sill J.C., Katusic Z. Endothelial L-arginine pathway and relaxations to vasopressin in canine basilar artery. Am. J. Physiol. 264:1993;H413-H418.
11. Faraci W.S., Nagel A.A., Verdries K.A., Vincent L.A., Xu H., Nichols L.E., Labasi J.M., Salter E.D., Pettipher E.R. 2-Amino-4-methylpyridine as a potent inhibitor of inducible NO synthase activity in vitro and in vivo. Br. J. Pharmacol. 119(6):1996;1101-1108.
12. Fujiwara S., Ito Y., Kuriyama H., Suzuki H. Diltiazem-induced vasodilation of smooth muscle cells of the canine basilar artery. Br. J. Pharmacol. 75:1982;455-467.
13. 2+ current. J. Physiol. 507:1998;771-781.
14. G-methyl-L-arginine causes endothelium-dependent contraction and inhibition of cyclic GMP formation in artery and vein. Proc. Natl. Acad. Sci. USA. 87:1990;4430-4434.
15. Harder D.R., Gebremedhin D., Narayanan J., Jefcoat C., Falck J.R., Campbell W.B., Roman R. Formation and action of a P-450 4A metabolite of arachidonic acid in cat cerebral microvessels. Am. J. Physiol. 266:1994;H2098-H2107.
16. Harder D.R., Lange $$$, Gebremedhin D., Birks E.K., Roman R.J. Cytochrome P450 metabolites of arachidonic acid as intracellular signaling molecules in vascular tissue. Vasc. Res. 34:1997;237-243.
17. Haburcak M., Wei L., Viana F., Prenen J., Droogmans G., Nilius B. Calcium-activated potassium channels in cultured human endothelial cells are not directly modulated by nitric oxide. Cell Calcium. 21:1997;291-300.
18. Iadecola C., Beitz A.J., Renno W., Xu X., Mayer B., Zhang F. Nitric oxide synthase-containing neural processes on large cerebral arteries and cerebral microvessels. Brain Res. 606:1993;148-155.
19. Ignarro L.J. Biosynthesis and metabolism of emdothelium-derived nitric oxide. Annu. Rev. Pharmacol. Toxicol. 30:1990;535-560.
20. + current and transient outward currents in human capillary endothelial cells. J. Membr. Biol. 167:1999;53-64.
21. Julou-Schaeffer G., Freslon J.L. Compared effects of calcium entry blockers on calcium-induced tension in rat isolated cerebral and peripheral resistance vessels. Naunyn-Schmiedeberg's Arch. Pharmacol. 336:1987;670-676.
22. G-monomethyl-L-arganine in canine basilar artery. Am. J. Physiol. 264:1991;H1245-H1250.
23. Kestler H.A., Janko S., Haussler U., Muche R., Hombach V., Hoher M., Wiecha J. A remark on the high-conductance calcium-activated potassium channel in human endothelial cells. Res. Exp. Med. 198:1998;133-143.
24. Kikkawa K., Murata S., Nagao T. Calcium antagonistic and spasmolytic activities of a new 1,5-benzothiazepine derivatives in isolated canine and monkey arteries. Arzneim.-Forsch. Drug Res. 38:1988;526-531.
25. Knowles R.G., Moncada S. Nitric oxide synthase in mammals. Biochem. J. 298:1994;242-249.
26. 2+ concentration in the production of endothelial nitric oxide and the control of vascular tone. Br. J. Pharmacol. 101:1990;489-493.
27. 2+-dependently converts L-arginine into an activator of soluble guanylate cyclase. Biochem. Biophys. Res. Commun. 164:1989;678-685.
28. Moncada S., Palmer R.M.J., Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:1991;109-142.
29. G-nitro-L-arginine (N5-[imino (nitro-amino) methyl]-L-ornithine) impairs endothelium-dependent dilations by inhibiting cytosolic nitric oxide synthesis from L-arginine. Naunyn. Schmiedeberg's Arch. Pharmacol. 34:1990;143-147.
30. 2+-activated potassium channels and ATP-sensitive potassium channels as modulators of vascular tone. Tred. Cardiovasc. Med. 3:1993;54-60.
31. Nelson M.T., Quayle J.M. Physiological roles and properties of potassium channels in arterial smooth muscle. Am. J. Physiol. 268:1995;C799-C822.
32. Nozaki K., Moskowitz M.A., Maynard K.I., Koketsu N., Dawson T.M., Bredt D.S., Snyder S.H. Possible origins and distribution of immunoreactive nitric oxide synthase-containing nerve fibers in cerebral arteries. J. Cereb. Blood Flow Metab. 13:1993;70-79.
33. Palmer R.M.J., Moncada S. A novel citrulline-forming enzyme implicated in the formation of nitric oxide by vascular endothelial cells. Biochem. Biophys. Res. Commun. 158:1989;348-352.
34. Palmer R.M.J., Ress D.D., Ashton D.S., Moncada S. L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem. Biophys. Res. Comm. 153:1988;1251-1256.
35. Rees D.D., Palmer R.M.J., Schultz R., Hodson H.F., Moncada S. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br. J. Pharmacol. 101:1990;746-752.
36. Robertson B.E., Schubert R. cGMP-dependent protein kinase activates Ca-activated K channels in cerebral artery smooth muscle cells. Am. J. Physiol. 265:1993;C299-C303.
37. Sessa W.C. The nitric oxide synthase family of proteins. J. Vasc. Res. 31:1994;131-143.
38. + channel activity and vascular tone in renal arterioles. Circ. Res. 83:1998;1069-1079.
39. Suzuki H., Fujiwara S. Neurogenic electrical response of single smooth muscle cells of the dog middle cerebral artery. Circ. Res. 51:1982;751-759.
40. Toda N., Okamura T. Neurogenic nitric oxide (NO) in the regulation of cerebroarterial tone. J. Chem. Neuroanat. 10:1996;259-265.
41. Toda N., Hatano Y., Hayashi S. Modifications by stretches of the mechanical response of isolated cerebral and extracerebral arteries to vasoactive agents. Pflugers Arch. 374:1978;73-77.
42. G-nitro-L-arginine in isolated dog and monkey cerebral arteries. Stroke. 24:1993;1584-1589.
43. Topouzis S., Schott C., Stoclet J.C. Participation of endothelium-derived relaxing factor and role of cyclic GMP in inhibitory effects of endothelium on contractile responses elicited by α-adrenoceptor agonists in rat aorta. J. Cardiovasc. Pharmacol. 18:1991;670-678.
44. Vane J.R. Control of the circulation by endothelial mediators. Int. Arch. Allergy. Immunol. 101:1993;333-345.
45. Vazquez J., Feigenbaum P., Katz G., King V.F., Reuben J.P., Roy-Contancin L., Slaughter R.S., Kaczorowski G.J., Garcia M.L. Characterization of high affinity binding sites for charybdotoxin in sarcolemmal membranes from bovine aortic smooth muscle. Evidence for a direct association with the high conductance calcium-activated potassium channel. J. Biol. Chem. 264:1989;20902-20909.
46. + channels inhibits proliferation of human endothelial cells induced by basic fibroblast growth factor. J. Vasc. Res. 35:1998;363-371.
47. + channel in renal arterioles. Am. J. Physiol. 270:1996;R228-R237.